Skip to main content
SpringerLink
Log in

Combination Antiretroviral Therapies for HIV

Some Economic Considerations

  • Chapter
Book cover Psychosocial and Public Health Impacts of New HIV Therapies

Part of the book series: AIDS Prevention and Mental Health ((APMH))

  • 76 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adler, M. W. (1998). Antiretrovirals for developing world. Lancet, 351, 232.

    Article  PubMed  CAS  Google Scholar 

  • Allen, U. D., Read, S., & Gafni, A. (1992). Zidovudine for chemoprophylaxis after occupational exposure to HIV-infected blood: An economic analysis. Clinical Infectious Diseases, 14, 822–830.

    PubMed  CAS  Google Scholar 

  • American Health Consultants. (1996). CDC: Avoid preventive therapy for sexual risk. AIDS Alert, 11(7), 75–76.

    Google Scholar 

  • Anderson, D. J., O’Brien, T. R., Politch, J. A., Martinez, A., Seage, G. R., Padian, N., Horsburgh, C. R., & Mayer, K. H. (1992). Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. Journal of the American Medical Association, 267, 2769–2774.

    PubMed  CAS  Google Scholar 

  • Anderson, R. M., & May, R. M. (1988). Epidemiological parameters of HIV transmission. Nature, 333, 514–519.

    PubMed  CAS  Google Scholar 

  • Anderson, R. M., Gupta, S., & May, R. M. (1991). Potential of community-wide chemotherapy or immunotherapy to control the spread of AIDS. Nature, 350, 356–359.

    Article  PubMed  CAS  Google Scholar 

  • Baker, M. (1997). HIV survives drug onslaught by hiding out in T cells. Science, 278, 1227.

    Google Scholar 

  • Berrios, D. C., Hearst, N., Coates, T. J., Stall, R., Hudes, E. S., Turner, H., Eversley, R., & Catania, J. (1993). HIV antibody testing among those at risk for infection. Journal ofthe American Medical Association, 270, 1576–1580.

    CAS  Google Scholar 

  • Boswell, S. L., Mayer, K. H., Goldstein, R. S., Tucker, L., Xu, C., & Anderson, D. (1997, January 22–26). The effect of HIV protease inhibitors on seminal proviral DNA. Fourth Conference on Retroviruses and Opportunistic Infections (Abstract no. 426). Washington, DC.

    Google Scholar 

  • Brookmeyer, R., & Gail, M. H. (1994). AIDS epidemiology: A quantitative approach. New York: Oxford University Press.

    Google Scholar 

  • Byrn, R. A., Zhang, D., Eyre, R., McGowan, K., & Kiessling, A. A. (1997). HIV-1 in semen: An isolated virus reservoir. Lancet, 350, 1141.

    Article  PubMed  CAS  Google Scholar 

  • Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastara, P. U., Marcus, M., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., Bell, D. M., & the Centers for Disease Control and Prevention Needlestick Surveillance Group (1997). A case-control study of HIV seroconversion in health care workers after percutaneous exposure. New England Journal of Medicine, 337, 1485–1490.

    Article  PubMed  CAS  Google Scholar 

  • Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., & Volberding, P. A. (1996). Antriretroviral therapy for HIV infection in 1996: Recommendations of an international panel. Journal of the American Medical Association, 276, 146–154.

    Article  PubMed  CAS  Google Scholar 

  • Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., & Volberding, P. A. (1997). Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society—USA panel. Journal of the American Medical Association, 277, 1962–1969.

    Article  PubMed  CAS  Google Scholar 

  • Centers for Disease Control. (1990). Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding post-exposure use. Morbidity and Mortality Weekly Report, 39 (no. RR-1).

    Google Scholar 

  • Centers for Disease Control. (1995). Case-control study ofHIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood—France, United Kingdom, and United States, January 1988–August 1994. Morbidity and Mortality Weekly Report, 44, 929–933.

    Google Scholar 

  • Centers for Disease Control. (1996). Update: Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV Morbidity and Mortality Weekly Report, 45, 468–472.

    Google Scholar 

  • Chancellor, J. V., Hill, A. M., Sabin, C. A., Simpson, K. N., & Youle, M. (1997). Modeling the cost-effectiveness of lamivudine/zidovudine combination therapy in HIV infection. Pharmacoeconomics, 12, 54–66.

    Article  PubMed  CAS  Google Scholar 

  • Chirianni, A., Perna, E., Liuzzi, G., D’Abbraccio, M., Bonadies, G., Paone, G., Foggia, M., Patricelli, V., & Piazza, M. (1992, June 19–24).Absence of anti-HIV seroconversion in heterosexual partners of HIV patients treated with zidovudine. International Conference on AIDS (Abstract no. PoC 4530).

    Google Scholar 

  • Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Basset, R. L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitare, C., McAuliffe, V. J., Friedman, H. M., Merigan, T. C., Reichman, R. C., Hooper, C., & Vorey, L. (1996). Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and lamivudine. New England Journal of Medicine, 334, 1011–1017.

    Article  PubMed  CAS  Google Scholar 

  • Cook, J., Dasbach, E., Coplan, P., Markson, L., Tan, C., Nguyen, B. Y., Meibohm, A., & Chodakewitz, J. (1997, January 22–26). Using HIV viral RNA to estimate the cost-effectiveness of indinavir alone and in combination. Fourth Conference on Retroviruses and Opportunistic Infections (Abstract no. 265). Washington DC.

    Google Scholar 

  • Deeks, S. G., Loftus, R., Cohen, P., Chin, S., & Grant, R. (1997, September 28–October 1). Incidence and predictors of virologic failure to indinavir or ritonavir in an urban health clinic. Thirty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract no. L2). Toronto, Ontario, Canada.

    Google Scholar 

  • Deeks, S. G., Smith, M., Holodniy, M., & Kahn, J. O. (1997). HIV-1 protease inhibitors: A review for clinicians. Journal of the American Medical Association. 277, 145–153.

    Article  PubMed  CAS  Google Scholar 

  • Dilley, J. W., Woods, W. J., & McFarland, W. (1997). Are advances in treatment changing views about high-risk sex? New England Journal of Medicine, 337, 501–502.

    Article  PubMed  CAS  Google Scholar 

  • Feder, H. M., & Milch, L. M. (1997). Viral load and combination therapy for human immunodeficiency virus. New England Journal of Medicine, 336, 959–960.

    PubMed  Google Scholar 

  • Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., Gallant, J., Markowitz, M., Ho, D. D., Richman, D. D., & Siliciano, R. F. (1997). Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science, 278, 1295–1300

    Article  PubMed  CAS  Google Scholar 

  • Fiore, J. R., Zhang, Y. J., Björndal, A., Di Stefano, M., Angarano, G., Pastore, G., & Fenyö, E. M. (1997). Biological correlates of HIV-1 heterosexual transmission. AIDS, 11, 1089–1094.

    Article  PubMed  CAS  Google Scholar 

  • Freidland, G. H., & Klein, R. S. (1987). Transmission of the human immunodeficiency virus. New England Journal of Medicine, 317, 1125–1135.

    Google Scholar 

  • Gilliam, B. L., Dyer, J., Fiscus, S., Marcus, C., Zhou, S., Wathen, L., Freimuth, W. W., Cohen, M. S., & Eron, J. J. (1997). Effects of reverse transcriptase inhibitor therapy on HIV-1 viral burden in semen. Journal of Acquired Immune Deficiency Syndromes, 15, 54–60.

    CAS  Google Scholar 

  • Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.

    Google Scholar 

  • Gorman, C. (1997, June 23). If the condom breaks. Time

    Google Scholar 

  • Gostin, L. O., Lazzarini, Z., Alexander, D., Brandt, A. M., Mayer, K. H., & Silverman, DC. (1994). HIV testing, counseling, and prophylaxis after sexual assault. Journal of the American Medical Association. 271, 1436–1444.

    PubMed  CAS  Google Scholar 

  • Guinan, M. E., Farnham, P. G., & Holtgrave, D. R. (1994). Estimating the value of preventing a human immunodeficiency virus infection. American Journal of Preventive Medicine, 10, 1–4.

    PubMed  CAS  Google Scholar 

  • Gupta, P., Mellors, J., Kingsley, L., Riddler, S., Singh, M. K., Schreiber, S., Cronin, M., & Rinaldo, C. R. (1997). High viral load in semen of human immunodeficiency virus type I-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. Journal of Virology, 71, 6271–6275.

    PubMed  CAS  Google Scholar 

  • Hamed, K. A., Winters, M. A., Holodniy, M., Katzenstein, D. A., & Merigan, T. C. (1993). Detection of human immunodeficiency virus type 1 in semen: Effects of disease stage and nucleoside therapy. Journal of Infectious Diseases, 178, 798–802.

    Google Scholar 

  • Hénin, Y., Mandelbrot, L., Henrion, R., Pradinaud, R., Coulaud, J. P., & Montagnier, L. (1993). Virus secretion in the cervicovaginal secretions of pregnant and non-pregnant HIV-infection women. Journal ofAcquired Immune Deficiency Syndromes and Human Retrovirology, 6, 72–75.

    Google Scholar 

  • HIV antiviral drug guide 1998. (1998, January–February). Positively Aware, 28–42.

    Google Scholar 

  • Hogg, R. S., Anis, A., Weber, A. E., O’shaughnessy, M. V., & Schechter, M. T. (1997). Triple-combination therapy in sub-Saharan Africa. Lancet, 350, 1406.

    Article  PubMed  CAS  Google Scholar 

  • Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 642–654.

    Article  PubMed  CAS  Google Scholar 

  • Holmberg, S. D., Horsburgh, C. R., Ward, J. W., & Jaffe, H. W. (1989). Biologic factors in the sexual transmission of human immunodeficiency virus. Journal of Infectious Diseases, 160, 116–125.

    PubMed  CAS  Google Scholar 

  • Holtgrave, D. R., & Pinkerton, S. D. (1997). Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 54–62.

    PubMed  CAS  Google Scholar 

  • Holtgrave, D. R., & Pinkerton, S. D. (l998a). The cost-effectiveness of small group and community-level interventions. In D. R. Holtgrave (Ed.), Handbook of economic evaluation of HIV prevention programs (pp. 120–127). New York: Plenum.

    Google Scholar 

  • Holtgrave, D. R., & Pinkerton, S. D. (1998b). The economics of HIV primary prevention. In J. L. Peterson & R. J. DiClemente (Eds.), Handbook of HIV prevention. New York Plenum.

    Google Scholar 

  • Holtgrave, D. R., Qualls, N. L., & Graham, J. D. (1996). Economic evaluation of HIV prevention programs. Annual Review of Public Health, 17, 467–488.

    Article  PubMed  CAS  Google Scholar 

  • Jacquez, J. A., Koopman, J. S., Simon, C. P., & Longini, I. M. (1994). Role ofprimary infection in epidemics of HIV infection in gay cohorts. Journal ofAcquired Immune Deficiency Syndromes, 7, 1169–184.

    CAS  Google Scholar 

  • Jurriaans, S., Vernazza, P. L., Goudsmit, J., Boogaard, J., & Van Gemen, B. (1996, July 7–12).HIV-1 viral load in semen versus blood plasma. International Conference on AIDS (Abstract Th.A.4036). Vancouver, British, Columbia, Canada.

    Google Scholar 

  • Kaplan, R. M., & Bush, J. W. (1982). Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology, 1, 61–80.

    Google Scholar 

  • Katz, M. H., & Gerberding, J. L. (1997). Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. New England Journal of Medicine, 336, 1098–1100.

    Google Scholar 

  • Keeler, E., & Cretin, S. (1983). Discounting life savings and other nonmonetary effects. Management Science, 29, 300–306.

    Article  Google Scholar 

  • Kelly, J. A., Otto-Salaj, L. L., Sikkema, K. J., Pinkerton, S. D., & Bloom, F. R. (1998). Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention. Health Psychology, 17, 310–319.

    PubMed  CAS  Google Scholar 

  • Kimball, A. M., Suarez, R., Gonzalez, R., Zessler, L., & Zacarias, F. (1990, June 20–23). The feasibility of providing AZT through national AIDS programs in Latin America: What would it cost? International Conference on AIDS (abstract no. S.D.774).

    Google Scholar 

  • Krieger, J. N., Coombs, R. W., Collier, A. C., Ross, S. O., Chaloupka, K., Cummings, D. K., Murphy, V. L., & Corey, L. (1991). Recovery of human immunodeficiency virus type 1 from semen: Minimal impact of of stage of infection and current antiviral chemotherapy. Journal of Infectious Diseases, 161, 386–388.

    Google Scholar 

  • Lee, T.-H., Sakahara, N., Fiebig, E., Busch, M. P., O’Brien, T. R., & Herman, S. A. (1996). Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-I from infected transfusion recipients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 427–428.

    PubMed  CAS  Google Scholar 

  • Lennox, J., Ellerbrock, T. V., Palmore, M., Hart, C., Schnell, C., Busch, T., Evans-Strickfaden, T., & Conley, L. (1997, January 22–26). The effect of HIV protease inhibitors on seminal proviral DNA. Fourth Conference on Retroviruses and Opportunistic Infections (Abstract no. 498), Washington DC.

    Google Scholar 

  • Li, R. W., Skolnik, P. R., & Wong, J. B. (1997, October 26–29). The cost-effectiveness of ritonavir for advanced HIV infection. Ninth Annual Meeting of the Society for Medical Decision Making (Abstract no. P-60), Houston, TX.

    Google Scholar 

  • Liuzzi, G., Chirianni, A., Bagnarelli, P., Clementi, M., Tullio Cataldo, P., Valenza, A., Bonadies, G., D’Abbraccio, M., & Piazza, M. (1996, July 7–12). Antiretroviral treatment of men infected with HIV-I and viral load in semen and saliva samples. International Conference on AIDS (Abstract Th.B.4340). Vancouver, British Columbia, Canada.

    Google Scholar 

  • Liuzzi, G., Chirianni, A., Clementi, M., Bagnarelli, P., Valenza, A., Tullio Cataldo, P., & Piazza, M. (1996). Analysis of HIV-1 load in blood, semen and saliva: Evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS, 10, F51–F56.

    PubMed  CAS  Google Scholar 

  • Macready, N. (1997). Investigators to study morning-after AIDS treatment. Lancet, 349, 780.

    PubMed  CAS  Google Scholar 

  • Martin, L. N, Murphey-Corb, M., Soike, K. F., Davison-Fairburn, B., & Baskin, G. B. (1993). Effects of initiation of 3’-azido,3’dideoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. Journal of Infectious Diseases, 168, 825–835.

    PubMed  CAS  Google Scholar 

  • Mastro, T. D., & de Vincenzi, I. (1996). Probabilities of sexual HIV-1 transmission. AIDS, 10(Suppl. A), S75–S82.

    PubMed  Google Scholar 

  • Mathes, L. F., Polas, P. J., Hayes, K. A., Swenson, C. L., Johnson, S., & Kociba, G. J. (1992). Pre-and post-exposure chemoprophylaxis: Evidence that 3’-azido-3’dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response. Antimicrobial Agents and Chemotherapy, 36,2715–2721.

    PubMed  CAS  Google Scholar 

  • May, R. M., & Anderson, R. M. (1987). Transmission dynamics of HIV infection. Nature, 326, 137–142.

    PubMed  CAS  Google Scholar 

  • Mellors, J. W. (1997). Clinical implications of resistance and cross-resistance to HIV protease inhibitors. Infections in Medicine (Suppl., HIV protease inhibitors: When and how they should be used), 32–38.

    Google Scholar 

  • Melvin, A. J., Burchett, S. K., Watts, D. H., Hitti, J., Hughes, J. P., McLellan, C. L., King, P. D., Johnson, E. J., Williams, B. L., Frenkel, L. M., & Coombs, R. W. (1997). Effect of pregnancy and zidovudine therapy on viral load in HIV-I infected women. Journal ofAcquired Immune Deficiency Syndromes and Human Retrovirology, 14, 232–236.

    CAS  Google Scholar 

  • Moore, R. D., & Bartlett, J. G. (1996). Combination antiretroviral therapy in HIV infection: An economic perspective. Pharmacoeconomics, 10, 109–113.

    PubMed  CAS  Google Scholar 

  • Mouton, Y., Alfandari, S., Valette, M., Cartier, F., Dellamonica, P., Humbert, G., Lang, J. M., Massip, P., Mechali, D., Leclercq, P., Modai, J., & Portier, H. (1997). Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS, 11, F101–F105.

    PubMed  CAS  Google Scholar 

  • Musicco, M., Lazzarin, A., Nicolosi, A., Gasparini, M., Costigliola, P., Arici, C., & Saracco, A. (1994). Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Archives of Internal Medicine, 154, 1971–1976.

    Article  PubMed  CAS  Google Scholar 

  • National Alliance of State and Territorial AIDS Directors (1997). State AIDS drug assistance programs: A national status report on access. Washington, DC: Author.

    Google Scholar 

  • New drugs for HIV infection. (1996) Medical Letter on Drugs and Therapeutics, 38, 35–38.

    Google Scholar 

  • Nicolosi, A. (1992). Human immunodeficiency virus (HIV-I): Infectivity transmission, risk behaviours and host susceptibility Functional Neurology, 7, 13–29.

    PubMed  CAS  Google Scholar 

  • O’Brien, T. R., Shaffer, N., & Jaffe, H. W. (1993). Acquisition and transmission ofHIV. In M. A. Sande & P. A. Volberding (Eds.), Medical management of AIDS (3rd ed., pp. 3–17). Philadelphia: Saunders.

    Google Scholar 

  • Operskalski, E. A., Stram, D. O., Busch, M. P., Huang, W., Harris, M., Dietrich, S. L., Schiff, E. R., Donegan, E., & Mosley, J. W. (1997). Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. American Journal of Epidemiology. 146, 655–661.

    PubMed  CAS  Google Scholar 

  • Paltiel, A. D., & Kaplan, E. H. (1991). Modeling zidovudine therapy: A cost-effectiveness analysis. Journal ofAcquired lmmune Deficiency Syndromes and Human Retrovirology, 4, 795–804.

    CAS  Google Scholar 

  • Patrick, D. L., & Erikson, P. (1993). Health status and health policy: Allocating resources to health care. New York: Oxford University Press.

    Google Scholar 

  • Pear, R. (1997, February 16). Expense means many can’t get drugs for AIDS. New York Times.

    Google Scholar 

  • Phillips, K. A., & Holtgrave, D. R. (1997). Using cost-effectiveness/cost-benefit analysis to allocate health resources: A level playing field? American Journal of Preventive Medicine, 13, 18–25.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S. D., & Abramson, P. R. (1994). An alternative model of the reproductive rate of HIV infection: Formulation, evaluation, and implications for risk reduction interventions. Evaluation Review, 18, 371–388.

    Google Scholar 

  • Pinkerton, S. D., & Abramson, P. R. (1996). Implications of increased infectivity in early-stage HIV infection: Application of a Bernoulli-process model of HIV transmission. Evaluation Review, 20, 516–540.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S. D., & Abramson, P. R. (1997). Effectiveness of condoms in preventing HIV transmission. SocialScience & Medicine, 44, 1303–1312.

    CAS  Google Scholar 

  • Pinkerton, S. D., & Abramson, P. R. (1998). The Bernoulli-process model of HIV transmission: Applications and implications. In D. R. Holtgrave (Ed.), Handbook of economic evaluation of HIV pre-vention programs (pp. 13–33). New York: Plenum.

    Google Scholar 

  • Pinkerton, S. D., & Holtgrave, D. R. (1998a). A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS and Behavior, 2, 189–201.

    Article  Google Scholar 

  • Pinkerton, S. D., & Holtgrave, D. R. (1998b). Prophylaxis after sexual exposure to HIV. Annals of lnternal Medicine, 129, 671.

    CAS  Google Scholar 

  • Pinkerton, S. D., & Holtgrave, D. R. (in press). Economic impact of delaying or preventing AIDS in persons with HIV. American Journal of Managed Care.

    Google Scholar 

  • Pinkerton, S. D., & Holtgrave, D. R. (under review). HIV treatment advances and the cost-effectiveness of prevention. AIDS.

    Google Scholar 

  • Pinkerton, S. D., Holtgrave, D. R., & Bloom, E R. (1997). Postexposure treatment of HIV. New England Journal of Medicine, 337, 500–501.

    PubMed  CAS  Google Scholar 

  • Pinkerton, S. D., Holtgrave, D. R., & Pinkerton, H. J. (1997). Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Archives of Internal Medicine, 157, 1972–1980.

    Article  PubMed  CAS  Google Scholar 

  • Pinkerton, S. D., Holtgrave, D. R., & Bloom, F. R. (1998). Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS, 12, 1067–1078.

    Article  PubMed  CAS  Google Scholar 

  • Rabkin, J. G., & Ferrando, S. (1997). A “second life” agenda: Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus of the acquired immunodeficiency syndrome. Archives of General Psychiatry, 54, 1049–1053.

    PubMed  CAS  Google Scholar 

  • Ragni, M. V, Faruki, H., & Kingsley, L. A. (1998). Heterosexual HIV-I transmission and viral load in hemophilic patients. Journal ofAcquired Immune Deficiency Syndromes, 17, 42–45.

    CAS  Google Scholar 

  • Ramsey, S. D., & Nettleman, M. D. (1992). Cost-effectiveness of prophylactic AZT following needlestick injury in health care workers. Medical Decision Making, 12, 142–148.

    PubMed  CAS  Google Scholar 

  • Rasheed, S., Li, Z., Xu, D., & Kovacs, A. (1996). Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women. American Journal of Obstetrics and Gynecology, 175, 122–130.

    Article  PubMed  CAS  Google Scholar 

  • Royce, R. A., Seña, A., Cates, W., & Cohen, M. S. (1997). Sexual transmission of HIV. New England Journal of Medicine, 336, 1072–1078.

    Article  PubMed  CAS  Google Scholar 

  • Seage, G., Mayer, K., Horsburgh, C., O’Brien, T., Politch, J., Tucker, L., & Anderson, D. (1993, June 6–11). Prospective evaluation of effect of zidovudine on detection of HIV-I in semen. International Conference on AIDS, Berlin, Germany. (Abstract no. PO-C3 1-3291).

    Google Scholar 

  • Speck, C. E., Coombs, R., Koutsky, L., Zeh, J., Corey, L., Hooton, T., Ross, S., & Krieger, J. (1996, July 7–12). Rates and determinants of HIV shedding in semen. International Conference on AIDS (Abstract no. We.C.334), Vancouver, British Columbia, Canada.

    Google Scholar 

  • Stephenson, J. (1997). The art of HAART: Researchers probe the potential and limits of aggressive HIV treatments. Journal of American Medical Association, 277, 614–616.

    CAS  Google Scholar 

  • Subbarao, S., Wright, T., Ellerbrock, T., Lennox, J. L., & Hart, C. (1998, February 1–5). Genotypic evidence of local HIV expression in the female genital tract. Fifth Conference on Retroviruses and Opportunistic Infections (Abstract no. 708). Chicago.

    Google Scholar 

  • Sweeney, P. A., Fleming, P. L., Karon, J. M., & Ward, J. W. (1997, September 28–October 1). A minimum estimate of the number of living HIV infected persons confidentially tested in the United States. Thirty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract no. 1–16). Toronto, Ontario, Canada.

    Google Scholar 

  • Torres, R. A., & Barr, M. (1997). Impact of combination therapy for HIV infection on inpatient census. New England Journal of Medicine, 336, 1532–1532.

    Article  Google Scholar 

  • Van Praag, E., & Perriens, J. H. (1996). Caring for patients with HIV and AIDS in middle income countries. British Medical Journal, 313, 440.

    PubMed  Google Scholar 

  • Vernazzi, P. L., Gilliam, B. L., Dyer, J., Fiscus, S. A., Eron, J. J., Frank, A. C., & Cohen, M. S. (1997). Quantification of HIV in semen: Correlation with antiviral treatment and immune status. AIDS, 11, 987–993.

    Google Scholar 

  • Vernazzi, P. L., Gilliam, B. L., Flep, M., Dyer, J., Frank, A. C., Fiscus, S. A., Cohen, M. S., & Eron, J. J. (1997). Effect ofantiviral treatment on the shedding ofHIV-1 in semen. AIDS, 11, 1249–1254.

    Google Scholar 

  • Weinstein, M. C., & Stason, W. B. (1977). Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 296, 716–721.

    Article  PubMed  CAS  Google Scholar 

  • Wiktor, S. Z., Ekpini, E. R., Sibailly, T. S., Diaby, L., Brown, T., Fransen, K., Steketee, R., Coulibaly, I. M., Laga, M., Kalish, M., & Greenberg, A. E. (1996, July 7–12). The effectiveness of oral zidovudine administered in late pregnancy in lowering plasma and cervicovaginal HIV-1 viral load in HIV-infected pregnant women in Abidjan Côte d’Ivoire. International Conference on AIDS (Abstract no. Tu.C.443). Vancouver, British Columbia, Canada.

    Google Scholar 

  • Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, H. V, Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997). Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science, 278, 1291–1294.

    Article  PubMed  CAS  Google Scholar 

  • Zhu, T., Wang, N., Carr, A., Nam, D. S., Moor-Jankowski, R., Cooper, D. A., & Ho, D. D. (1996). Genetic characterization of human immunodeficiency virus type l in blood and genetic secretions: Evidence for viral compartmentalization and selection during sexual transmission. Journal of Virology, 70, 3098–3107.

    PubMed  CAS  Google Scholar 

  • Zuger, A. (1997, June 10). “Morning after” treatment for AIDS. New York Times.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, 53202

    Steven D. Pinkerton

  2. Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, 30333

    David R. Holtgrave

Authors
  1. Steven D. Pinkerton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David R. Holtgrave
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Howard Brown Health Center and University of Illinois/Chicago School of Public Health, Chicago, Illinois

    David G. Ostrow M.D., Ph.D.

  2. Center for AIDS Intervention Research (CAIR), Medical College of Wisconsin, Milwaukee, Wisconsin

    Seth C. Kalichman Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Pinkerton, S.D., Holtgrave, D.R. (2002). Combination Antiretroviral Therapies for HIV. In: Ostrow, D.G., Kalichman, S.C. (eds) Psychosocial and Public Health Impacts of New HIV Therapies. AIDS Prevention and Mental Health. Springer, Boston, MA. https://doi.org/10.1007/0-306-47159-0_4

Download citation

  • DOI: https://doi.org/10.1007/0-306-47159-0_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45973-3

  • Online ISBN: 978-0-306-47159-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation